Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Higeta Shoyu is a venerable Japanese company, established in 1616, that has successfully diversified from its traditional soy sauce brewing roots into the biotechnology industry. The company utilizes its extensive expertise in fermentation and microbiology to offer specialized products and services for life science research and industrial applications. Central to its biotech portfolio is the proprietary Brevibacillus Expression System, a high-efficiency platform for the production of recombinant proteins. Higeta Shoyu is a leading global supplier of Nuclease P1 and provides comprehensive contract manufacturing services for protein expression. Their contributions support various sectors, including diagnostics, pharmaceuticals, and academic research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Higeta Shoyu.